SPIMACO cancels the MoU with Cooper Pharma Morocco

12/06/2012 Argaam

SPIMACO Pharmaceutical Company announced today on tadawul cancelling the memorandum of understanding signed earlier with Cooper Pharma Morocco Company for establishing oncology drugs factory in Morocco.

The company stated the reason for cancelling the MoU is the material change in prices of these drugs which will result in lower profitability.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.